The Nordic Precision Medicine forum brought industry leaders together to exchange ideas and insights on the significance of precision medicine, AI and Data in healthcare, and digital health-related issues. We shared insights into how we provide federated solutions for population genomics initiatives, helping to tackle the obstacles usually associated with patient data accessibility and usability. Lifebit's Chief Business Development Officer Thorben Seeger spoke about global efforts to deliver national Trusted Research Environments at scale. He also provided an update on our partnerships with Greece, the UK and Denmark.
″Lifebit’s presence in these important conferences and networking with key opinion leaders enables us to understand the local needs of Nordic, Scandinavia, and Baltic biobanks and their national genomic initiatives. ″
-Karl Quinn, Director of Biobanks (EMEA), Lifebit
%20(1)%20(1).png)
.png)
.jpeg)
Thorben Seeger
Chief Business Development Officer, Lifebit
Thorben Seeger leads Lifebit’s commercial operations. With over 14 years of experience in enterprise technology solutions, his innovation in the genomics field has established Lifebit as the leading software technology powering precision medicine programs worldwide, such as Genomics England & Hong Kong Genome Project. In addition, he guides partnerships with pharma giants like Boehringer Ingelheim, where Lifebit will deliver AI-powered insights.
Share This Page
More like this
3 strategies for RWD challenges in clinical research and trials
Thu 25 April 2024 - 59 Mins